Target intelligence / Profile preview

Nuclear factor kappa B pathway component (NF-κB pathway component)

Target
NF-κB pathway component
Molecular classification
Transcription factor (NF-κB family), Kinase (IκB kinase/IKK complex), Signaling adaptor protein
01

Overview

The Nuclear factor kappa B pathway comprises a family of transcription factors—including the canonical p65/RelA and p50 subunits—along with regulatory kinases such as the IKK complex. This pathway is central to cellular responses against stressors like cytokines, pathogens, oxidative stress, and DNA damage. Activation typically involves upstream signals that trigger the IKK complex to phosphorylate inhibitor proteins such as IκBα. Once phosphorylated, these inhibitors are degraded via ubiquitination pathways. The freed NF‑κB dimer then translocates into the nucleus where it binds DNA at κΒ sites to regulate genes involved in inflammation, immunity, cell proliferation/survival/apoptosis. Curcumin has been shown experimentally to inhibit this cascade by blocking upstream signals leading to IKK activation—thereby preventing downstream proinflammatory gene expression such as ICAM‑1 and IL‑8. Because this entry refers collectively to multiple components within the broader signaling network rather than a unique molecule or receptor with a standard name or abbreviation—and because curcumin modulates several points within this axis—the target description is overly broad for structured data extraction purposes. Curcumin potently inhibits cytokine-mediated NF-kappa B activation by blocking a signal leading to Ikappa B kinase activity. NF-kappa B plays a key role in regulating immune response...and is involved in cellular responses...such as stress and cytokines.

Other names
NF-κB signaling componentsNuclear factor kappa-light-chain-enhancer of activated B cells pathway proteinsIKK complex membersRelA/p65 subunitp50 subunitIκB kinase (IKK)Inhibitor of κB (IκB)
02

Mechanism of action

Inhibition of IKK activity leading to reduced phosphorylation/degradation of IκB and suppression of NF‑κB nuclear translocation

03

Biological functions

Signal transductionImmune response regulationInflammation mediationCell survival and apoptosis control
04

Disease associations

CancerInflammationNeurodegenerative disease
05

Safety considerations

Therapeutic targeting can risk immunosuppression or impaired cell survival due to the central role in immune responses
06

Interacting drugs

Curcumin

Beyond the preview

Go deeper on Nuclear factor kappa B pathway component (NF-κB pathway component).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor kappa B pathway component (NF-κB pathway component).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call